Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.

Lee J, Pedro S, Bares SH, Ozen G, Mikuls TR, Michaud K.

Open source

DOI
10.1177/1759720x261433254
Published
2026-03-25
Container
Ther Adv Musculoskelet Dis
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1759720x261433254,
  title = {Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.},
  author = {Lee J and  Pedro S and  Bares SH and  Ozen G and  Mikuls TR and  Michaud K.},
  year = {2026},
  journal = {Ther Adv Musculoskelet Dis},
  doi = {10.1177/1759720x261433254},
  url = {https://doi.org/10.1177/1759720x261433254}
}

RIS

TY  - JOUR
TI  - Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.
AU  - Lee J
AU  -  Pedro S
AU  -  Bares SH
AU  -  Ozen G
AU  -  Mikuls TR
AU  -  Michaud K.
PY  - 2026
JO  - Ther Adv Musculoskelet Dis
DO  - 10.1177/1759720x261433254
UR  - https://doi.org/10.1177/1759720x261433254
ER  - 

APA

J, L., S, P., SH, B., G, O., TR, M., & K., M. (2026). Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset.. Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720x261433254

Source records